Evaluation of paxalisib in GBM AGILE phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma Meeting Abstract
| Authors: | Mellinghoff, I. K.; Cloughesy, T.; Alexander, B.; Berry, D. A.; Buxton, M.; Cavenee, W.; Colman, H.; de Groot, J.; Ellingson, B. M.; Gordon, G. B.; Lassman, A. B.; Lim, M.; Khasraw, M.; Perry, J.; Sulman, E. P.; Weller, M.; Wen, P.; Alfred Yung, W. K.; Berry, N.; Graves, T.; Detry, M.; Viktoria Hyddmark, E. M.; Johnsson, A.; Kling, H.; McGlothlin, A.; Powell, A.; Untch, S.; Aquilanti, E.; Blondin, N.; Boulmay, B.; de la Fuente, M.; Drappatz, J.; Jordan, J.; Kaley, T. J.; Lobbous, M.; Mikkelsen, T.; Newton, H.; Owen, S.; Peters, K.; Schiff, D.; Sherman, W.; Weathers, S. P.; Youssef, M.; Friend, J.; Lee, E. |
| Abstract Title: | Evaluation of paxalisib in GBM AGILE phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma |
| Meeting Title: | 29th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) |
| Journal Title: | Neuro-Oncology |
| Volume: | 26 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2024 Nov 21-24 |
| Meeting Location: | Houston, TX |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-11-01 |
| Start Page: | viii328 |
| Language: | English |
| ACCESSION: | WOS:001362468400033 |
| DOI: | 10.1093/neuonc/noae165.1302 |
| PROVIDER: | wos |
| PMCID: | PMC11583046 |
| Notes: | Meeting Abstract: LTBK-02 (Citation ID: NOAE165.1302) -- Source: Wos |
